Serina Therapeutics, Inc.
SER- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001708599
In the last 90 days, Serina Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 27 institutions reported holding it in 13F filings for Q2 2026, worth $2.73M in total; no superinvestor holds it.
Q4 2022 vs. Q3 2022
How the institutions holding Serina Therapeutics, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 32 | 1 | 31 | 0 |
| Shares | 4.75M | 1.00K | 4.79M | +44.1K (+0.9%) |
| Value | $2.67M | $1.00K | $2.66M | −$9.48K (−0.4%) |
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (4)
Institutions that held Serina Therapeutics, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 52,381 | $28.9K | 0.00% |
| Advisory Services Network, LLC | 550 | $304 | 0.00% |
| CoreCap Advisors, LLC | 10 | $6 | 0.00% |
| GWM Advisors LLC | 1 | $0 | 0.00% |
Sold out (4)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Virtu Financial LLC | 20,590 | $12.0K |
| Millennium Management LLC | 17,313 | $10.0K |
| Citadel Advisors LLC | 10,029 | $6.00K |
| Trust Co of Vermont | 100 | $0 |
Not filed for Q4 2022 yet (1)
Institutions that held Serina Therapeutics, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Corsicana & Co. | 1,000 | $1.00K |